PASD1 and acute myeloid leukemia: Using immunocytochemistry with two well-characterised PASD1 monoclonal antibodies [40] we observed PASD1a and PASD1b expression in three AML patient samples: AML004, AML008 and AML014 (Fig 6) but not in the other 15 patient samples tested (AML001, AML003, AML006, AML009, AML013, AML015, AML018, AML019, AML021, AML023, AML026, ALL001, ALL002, CML001 and CML002).